QuidelOrtho (QDEL) EBIAT (2021 - 2026)

QuidelOrtho's EBIAT history runs 6 years deep, the most recent figure standing at -$91.8 million for Q1 2026.

• In Q1 2026, EBIAT fell 622.83% year-over-year to -$91.8 million; the TTM figure through Mar 2026 stood at -$1.2 billion (down 237.58% YoY), while the FY2025 annual figure was -$1.1 billion, up 44.84% from the prior year.
• EBIAT came in at -$91.8 million for Q1 2026 at QuidelOrtho, up from -$130.7 million in the prior quarter.
• In the past five years, EBIAT ranged from a high of $479.9 million in Q2 2022 to a low of -$1.7 billion in Q1 2024.
• A 5-year average of -$184.3 million and a median of -$53.2 million in 2023 frame the typical range for EBIAT.
• Across the five-year window, EBIAT soared 232.98% in 2022 and sank 3595.9% in 2024, its largest moves.
• QuidelOrtho's EBIAT stood at $19.2 million in 2022, then sank by 2852.6% to -$528.5 million in 2023, then surged by 66.24% to -$178.4 million in 2024, then climbed by 26.74% to -$130.7 million in 2025, then advanced by 29.76% to -$91.8 million in 2026.
• According to Business Quant data, EBIAT over the past three periods registered -$91.8 million, -$130.7 million, and -$733.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison